We have recently shown that the NLRP3 inflammasome is activated in Aβ stimulated monocytes of individuals with a diagnosis of AD and mild cognitive impairment (MCI)15, a prodromal phase of Alzheimer’s disease. Here, NLRP3 is linked to Alzheimer disease.